Topic Hub
4 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 4 of 4 clinical reviews.
A detailed review of lisinopril safety signals in the FDA Adverse Event Reporting System (FAERS), covering angioedema, cough, hyperkalemia, renal events, and how post-market data has shaped prescribing guidance.
Read clinical reviewA comprehensive review of lisinopril's regulatory history across the FDA, EMA, and global agencies, including approval timelines, label updates, post-market surveillance, and current prescribing status.
Read clinical reviewA comprehensive review of lisinopril FDA label updates from 2020 through 2026, covering new safety warnings, post-market surveillance findings, and prescribing changes for this widely used ACE inhibitor.
Read clinical reviewA detailed comparison of how the European Medicines Agency and the U.S. FDA regulate lisinopril, covering approval history, labeling differences, post-market surveillance, and safety signals.
Read clinical review